Showing results (31-40 of 179) with videos related to
Sort By:
Pageof 18
Thrombosis and Haemostasis|May 4, 1992
Pharmacodynamic properties of long lasting butyryl heparin derivatives in the rabbitS Saivin, C Caranobe, M Petitou, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Distribution of 16 hemostatic laboratory variables assayed in 100 blood donorsY Cadroy, P Daviaud, S Saivin, et al.Thrombosis and Haemostasis|August 4, 1987
Antithrombotic and bleeding effects of a new synthetic direct thrombin inhibitor and of standard heparin in the rabbitY Cadroy, C Caranobe, A Bernat, et al.Thrombosis and Haemostasis|June 30, 1989
Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbitL Briant, C Caranobe, S Saivin, et al.Thrombosis and Haemostasis|May 29, 1999
Effects of heparin and related sulfated polysaccharides on tissue factor expression induced by mitogenic and non-mitogenic factors in human vascular smooth muscle cellsJ M Xuereb, J M Herbert, P Sie, et al.La Nouvelle Presse Medicale|October 9, 1982
[Increase in mean platelet volume in shock-related thrombocytopenia]N Dastugue, F Picheloup, P Sie, et al.British Journal of Haematology|July 1, 1991
Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatmentM Estivals, H Pelzer, P Sie, et al.Presse Medicale (Paris, France : 1983)|April 23, 1983
[Plasma fibronectin. Role in severe infections and intensive care]M Genestal, P Sie, B Hugot, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivativesF Dol, M Petitou, J Choay, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1980
Platelet production time, uricemia, and some hemostasis tests in pre-eclampsiaB Boneu, A Fournié, P Sie, et al.Pageof 18